How PX1 Tests Every SS-31 Lot (HPLC, MS, Endotoxin)
Ensuring experimental reproducibility in mitochondrial and cellular research requires uncompromised chemical purity and identity verification. PX1 Research subjects every batch of SS-31 (Elamipretide) to a rigorous multi-tier analytical battery—including RP-HPLC, ESI-MS mass spectrometry, and LAL endotoxin quantification—in independent ISO 17025 accredited facilities.
Quick answer
Ensuring experimental reproducibility in mitochondrial and cellular research requires uncompromised chemical purity and identity verification. PX1 Research subjects every batch of SS-31 (Elamipretide) to a rigorous multi-tier analytical battery—including RP-HPLC, ESI-MS mass spectrometry, and LAL endotoxin quantification—in independent ISO 17025 accredited facilities.
Key takeaways
- In cell culture models and isolated mitochondrial assays, experimental accuracy depends entirely on the fidelity of the chemical reagents utilized.
- Synthetic peptides generated via Solid-Phase Peptide Synthesis (SPPS) inherently present risk of micro-impurities.
- Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative method for determining chemical purity.
- While RP-HPLC establishes chemical purity, Mass Spectrometry (MS) confirms molecular identity.
Introduction to SS-31 Quality Control in Preclinical Research
In cell culture models and isolated mitochondrial assays, experimental accuracy depends entirely on the fidelity of the chemical reagents utilized. SS-31 (also known as Elamipretide or MTP-131) is a synthetic tetrapeptide (D-Arg-2',6'-Dmt-Lys-Phe-NH2) widely studied for its targeted interaction with cardiolipin within the inner mitochondrial membrane. When researchers evaluate mitochondrial bioenergetics, electron transport chain kinetics, or reactive oxygen species (ROS) scavenging mechanisms, any uncharacterized impurities can alter baseline cellular responses and introduce experimental bias.
To prevent analytical artifacts, PX1 Research enforces strict quality control verification for every lot of our SS-31 product. Through transparent documentation accessible via our centralized research hub, principal investigators can verify that their compounds meet or exceed stringent physical and chemical specifications prior to starting in vitro experiments.
Why Rigorous Lot Validation Matters for SS-31 In Vitro Research
Synthetic peptides generated via Solid-Phase Peptide Synthesis (SPPS) inherently present risk of micro-impurities. These can include deletion sequences, truncated peptides, incomplete deprotection byproducts, and residual organic solvents such as dimethylformamide (DMF) or trifluoroacetic acid (TFA). Because SS-31 functions via specific electrostatic and hydrophobic interactions with cardiolipin, truncated sequences lacking the 2',6'-dimethyltyrosine (Dmt) residue fail to mimic full-length SS-31 activity and may act as competitive inhibitors in receptor-binding assays.
Furthermore, residual synthesis solvents or high levels of bacterial endotoxins can cause non-specific cytotoxicity in primary cell cultures or isolated organelle preparations. Establishing an SS-31 third party tested workflow ensures that each vial contains verified, full-length peptide free from cellular toxicants that could skew metabolic readouts.
Step 1: Purity Quantitation via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative method for determining chemical purity. In our standard analytical protocol, an aliquot of the synthesized batch is passed through a C18 stationary phase column utilizing an acetonitrile/water gradient containing 0.1% trifluoroacetic acid as an ion-pairing agent.
Chromatographic separation isolates the main peak of SS-31 from related peptide impurities, such as D-diastereomers or sequence deletion fragments. Ultraviolet (UV) detection at 214 nm (the peptide backbone absorption wavelength) and 280 nm allows for precise integration of peak areas. To pass PX1 quality standards, an SS-31 lot must exhibit an RP-HPLC area percent purity of ≥98.0%, ensuring minimal chromatographic interference in downstream biochemical assays.
Step 2: Molecular Weight and Identity Verification via Mass Spectrometry (MS)
While RP-HPLC establishes chemical purity, Mass Spectrometry (MS) confirms molecular identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry is employed to determine the precise mass-to-charge ratio (m/z) of the molecule.
The theoretical monoisotopic molecular weight of SS-31 (C32H49N9O5) is approximately 639.8 g/mol. ESI-MS analysis yields clear protonated molecular ion peaks (e.g., [M+H]+ and [M+2H]2+) matching the calculated molecular mass within strict error margins (±0.5 Da). Confirming mass identity rules out sequence transposition, incorrect amino acid substitution, or failure of side-chain deprotection during synthesis, providing certainty that researchers are working with the true target peptide.
Step 3: Determining Net Peptide Content vs. Total Lyophilized Mass
A common point of confusion in laboratory calculations is the distinction between total gross mass and net peptide content. Lyophilized peptide cakes contain not only the active peptide sequence, but also bound counterions (typically TFA or acetate) and residual moisture absorbed during processing. Consequently, a 10 mg vial of lyophilized powder does not contain 10 mg of pure peptide by weight.
PX1 conducts Elemental Analysis (nitrogen content analysis) or quantitative Amino Acid Analysis (AAA) to establish the exact Net Peptide Content (typically ranging between 80% and 90% of gross weight). This metric is detailed on every batch analysis certificate, allowing investigators to accurately adjust molar concentration calculations in quantitative biochemical protocols.
Step 4: Endotoxin Quantitation Using the Chromogenic LAL Assay
Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—are potent activators of immune responses in biological models. Even minute concentrations of endotoxin can induce pro-inflammatory cytokine expression in cell lines, confounding research focused on mitochondrial oxidative stress or cellular senescence.
PX1 tests every lot of SS-31 for endotoxin contamination using the quantitative Chromogenic Limulus Amebocyte Lysate (LAL) assay. All lots distributed for laboratory research must maintain endotoxin levels strictly below <0.05 EU/mg. This low endotoxin threshold guarantees that observed cellular responses are attributable solely to the compound under investigation, rather than innate immune activation by bacterial contaminants.
Step 5: Bioburden Testing and Sterile Fill Integrity
Following synthesis and purification, SS-31 is reconstituted in sterile water for injection (WFI), filtered through a 0.22-micron polyethersulfone (PES) membrane in an ISO Class 5 cleanroom environment, and aliquoted into sterile glass vials prior to lyophilization.
Representative vials from each filling run undergo microbial limit testing (bioburden analysis) to confirm the absence of viable aerobic bacteria, yeast, and mold. Additionally, container closure integrity testing is performed to ensure that the stoppers and aluminum crimps maintain a hermetic seal, protecting the delicate lyophilized matrix from atmospheric moisture degradation during storage.
Comparative Analytical Profiles: SS-31 vs. Other Mitochondrial Research Peptides
Analytical protocols must be tailored to the structural characteristics of specific peptides. For instance, while SS-31 is a small, highly cationic tetrapeptide requiring specialized ion-pairing agents for RP-HPLC resolution, larger mitochondrial research peptides demand distinct chromatographic conditions. Comparative studies often evaluate SS-31 alongside compounds like MOTS-c, a 16-amino-acid peptide encoded in the mitochondrial genome, Humanin, a 24-amino-acid microprotein, and growth hormone secretagogues such as GHRP-6.
Because peptides vary widely in hydrophobic indices, molecular weight, and secondary structure formation, PX1 customizes chromatographic gradient profiles and mass spectrometry calibration ranges for each compound class. This tailored analytical approach ensures that purity and identity measurements remain robust across diverse peptide families.
Chain of Custody, Retained Archival Samples, and Lot Batching
To ensure complete traceability throughout the product lifecycle, PX1 maintains a rigorous lot-batching system. Every production run is assigned a unique, immutable lot number that tracks the batch from initial amino acid coupling through final lyophilization and packaging.
For every batch produced, archival samples are retained under monitored ultra-low temperature (-80°C) conditions in our facility. In the event of an analytical query or longitudinal stability investigation, these retained samples allow our quality assurance team to perform re-testing under standardized laboratory conditions. Laboratories procuring bulk quantities via our wholesale portal receive consistent lot-specific documentation linked directly to these archival controls.
How to Verify and Match Your SS-31 COA to the Vial Lot
Every vial of SS-31 shipped by PX1 features a clear label containing the compound name, mass, storage parameters, and a unique lot number. Researchers can verify their product's analytical credentials by cross-referencing this lot number with our public repository.
To review the raw analytical data for your specific vial, navigate to our dedicated Certificate of Analysis database. Enter the lot number printed on your vial to view or download the complete PDF report. Each COA includes the raw RP-HPLC chromatogram with peak integration tables, the ESI-MS mass spectrum showing observed mass peaks, the LAL endotoxin result, and net peptide content percentages.
Reconstitution Protocols and Laboratory Handling Practices
Lyophilized SS-31 should be stored at -20°C or -80°C upon receipt to maintain long-term stability. Prior to opening, allow the vial to equilibrate to room temperature to prevent condensation from forming inside the container, which can cause premature hydrolysis.
When preparing stock solutions for in vitro experiments, dissolve the lyophilized cake in sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). For accurate volumetric calculations, researchers should utilize our interactive reconstitution calculator to determine precise solvent volumes based on net peptide content. To explore our full catalog of validated compounds for preclinical research, visit our all peptides directory.
Frequently Asked Questions
What analytical methods are used to confirm that SS-31 is third party tested?
PX1 utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity quantitation, Electrospray Ionization Mass Spectrometry (ESI-MS) for mass identity verification, and the Chromogenic LAL assay for endotoxin quantitation. All testing is performed by independent ISO 17025 accredited analytical laboratories.
Why is net peptide content critical when preparing SS-31 working solutions?
Lyophilized peptide cakes contain bound counterions (such as TFA or acetate) and trace moisture, meaning active peptide weight is typically 80% to 90% of total mass. Knowing the net peptide content allows researchers to calculate true molar concentrations for precise bioassays.
What is the maximum allowable endotoxin limit for PX1 SS-31 lots?
Every lot of SS-31 distributed by PX1 must test below <0.05 EU/mg for endotoxins via the chromogenic LAL assay. This ensures minimal risk of non-specific immune activation or cytotoxicity in sensitive cell cultures.
How do I access the Certificate of Analysis (COA) for my specific SS-31 lot?
Locate the unique lot number printed on your vial label, then visit the PX1 COA lookup tool at /coa. Enter the lot number to view the complete analytical report, including raw HPLC chromatograms and MS spectra.
What mass spectrum value should be observed for SS-31 during testing?
SS-31 (C32H49N9O5) has a theoretical monoisotopic molecular weight of approximately 639.8 g/mol. Mass spectrometry testing confirms identity via primary protonated mass peaks ([M+H]+) matching this theoretical value within ±0.5 Da.
Does PX1 maintain retained samples for every SS-31 batch?
Yes. PX1 retains representative samples from every lyophilization run in ultra-low temperature (-80°C) storage. These samples serve as archival controls for stability monitoring and quality verification.
How should lyophilized SS-31 be stored upon arrival at the laboratory?
Lyophilized SS-31 should be stored at -20°C or -80°C for long-term stability. Avoid repeated freeze-thaw cycles after reconstitution, and allow vials to reach room temperature before opening to prevent moisture condensation.
Is SS-31 supplied by PX1 suitable for clinical or human use?
No. SS-31 supplied by PX1 Research is strictly intended for laboratory research use only (in vitro and animal model studies). It is not for human, clinical, or veterinary administration.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.